EXPLORE CONNECTIONS
Characterization of the impact of daclizumab beta on circulating natural killer cells by mass cytometry
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.